IBDEI0QV ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12605,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12605,1,3,0)
 ;;=3^Cerebrovascular Disease,Oth
 ;;^UTILITY(U,$J,358.3,12605,1,4,0)
 ;;=4^I67.89
 ;;^UTILITY(U,$J,358.3,12605,2)
 ;;=^5007388
 ;;^UTILITY(U,$J,358.3,12606,0)
 ;;=J32.8^^53^577^49
 ;;^UTILITY(U,$J,358.3,12606,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12606,1,3,0)
 ;;=3^Sinusitis,Chr,Oth
 ;;^UTILITY(U,$J,358.3,12606,1,4,0)
 ;;=4^J32.8
 ;;^UTILITY(U,$J,358.3,12606,2)
 ;;=^269890
 ;;^UTILITY(U,$J,358.3,12607,0)
 ;;=J32.4^^53^577^48
 ;;^UTILITY(U,$J,358.3,12607,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12607,1,3,0)
 ;;=3^Pansinusitis,Chr
 ;;^UTILITY(U,$J,358.3,12607,1,4,0)
 ;;=4^J32.4
 ;;^UTILITY(U,$J,358.3,12607,2)
 ;;=^5008206
 ;;^UTILITY(U,$J,358.3,12608,0)
 ;;=J40.^^53^577^8
 ;;^UTILITY(U,$J,358.3,12608,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12608,1,3,0)
 ;;=3^Bronchitis,Unspec
 ;;^UTILITY(U,$J,358.3,12608,1,4,0)
 ;;=4^J40.
 ;;^UTILITY(U,$J,358.3,12608,2)
 ;;=^17164
 ;;^UTILITY(U,$J,358.3,12609,0)
 ;;=J45.909^^53^577^4
 ;;^UTILITY(U,$J,358.3,12609,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12609,1,3,0)
 ;;=3^Asthma,Unspec,Uncomplicated
 ;;^UTILITY(U,$J,358.3,12609,1,4,0)
 ;;=4^J45.909
 ;;^UTILITY(U,$J,358.3,12609,2)
 ;;=^5008256
 ;;^UTILITY(U,$J,358.3,12610,0)
 ;;=J44.9^^53^577^9
 ;;^UTILITY(U,$J,358.3,12610,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12610,1,3,0)
 ;;=3^COPD,Unspec
 ;;^UTILITY(U,$J,358.3,12610,1,4,0)
 ;;=4^J44.9
 ;;^UTILITY(U,$J,358.3,12610,2)
 ;;=^5008241
 ;;^UTILITY(U,$J,358.3,12611,0)
 ;;=K21.9^^53^577^21
 ;;^UTILITY(U,$J,358.3,12611,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12611,1,3,0)
 ;;=3^GERD w/o Esophagitis
 ;;^UTILITY(U,$J,358.3,12611,1,4,0)
 ;;=4^K21.9
 ;;^UTILITY(U,$J,358.3,12611,2)
 ;;=^5008505
 ;;^UTILITY(U,$J,358.3,12612,0)
 ;;=N40.0^^53^577^20
 ;;^UTILITY(U,$J,358.3,12612,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12612,1,3,0)
 ;;=3^Enlarged Prostate w/o LUTS
 ;;^UTILITY(U,$J,358.3,12612,1,4,0)
 ;;=4^N40.0
 ;;^UTILITY(U,$J,358.3,12612,2)
 ;;=^5015689
 ;;^UTILITY(U,$J,358.3,12613,0)
 ;;=N40.1^^53^577^19
 ;;^UTILITY(U,$J,358.3,12613,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12613,1,3,0)
 ;;=3^Enlarged Prostate w/ LUTS
 ;;^UTILITY(U,$J,358.3,12613,1,4,0)
 ;;=4^N40.1
 ;;^UTILITY(U,$J,358.3,12613,2)
 ;;=^5015690
 ;;^UTILITY(U,$J,358.3,12614,0)
 ;;=L03.811^^53^577^10
 ;;^UTILITY(U,$J,358.3,12614,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12614,1,3,0)
 ;;=3^Cellulitis,Head (Except Face)
 ;;^UTILITY(U,$J,358.3,12614,1,4,0)
 ;;=4^L03.811
 ;;^UTILITY(U,$J,358.3,12614,2)
 ;;=^5009063
 ;;^UTILITY(U,$J,358.3,12615,0)
 ;;=L03.818^^53^577^11
 ;;^UTILITY(U,$J,358.3,12615,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12615,1,3,0)
 ;;=3^Cellulitis,Oth Sites
 ;;^UTILITY(U,$J,358.3,12615,1,4,0)
 ;;=4^L03.818
 ;;^UTILITY(U,$J,358.3,12615,2)
 ;;=^5009064
 ;;^UTILITY(U,$J,358.3,12616,0)
 ;;=L03.891^^53^577^35
 ;;^UTILITY(U,$J,358.3,12616,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12616,1,3,0)
 ;;=3^Lymphangitis,Head (Except Face),Acute
 ;;^UTILITY(U,$J,358.3,12616,1,4,0)
 ;;=4^L03.891
 ;;^UTILITY(U,$J,358.3,12616,2)
 ;;=^5009065
 ;;^UTILITY(U,$J,358.3,12617,0)
 ;;=L03.898^^53^577^36
 ;;^UTILITY(U,$J,358.3,12617,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12617,1,3,0)
 ;;=3^Lymphangitis,Oth Sites,Acute
 ;;^UTILITY(U,$J,358.3,12617,1,4,0)
 ;;=4^L03.898
 ;;^UTILITY(U,$J,358.3,12617,2)
 ;;=^5009066
 ;;^UTILITY(U,$J,358.3,12618,0)
 ;;=L03.90^^53^577^12
 ;;^UTILITY(U,$J,358.3,12618,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12618,1,3,0)
 ;;=3^Cellulitis,Unspec
 ;;^UTILITY(U,$J,358.3,12618,1,4,0)
 ;;=4^L03.90
